相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors
Lena-Louise Schuele et al.
GLIA (2021)
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
Victoria S. Marshe et al.
TRANSLATIONAL PSYCHIATRY (2021)
Role of DNA Methylation in Mediating Genetic Risk of Psychiatric Disorders
Anna Starnawska et al.
FRONTIERS IN PSYCHIATRY (2021)
Neurophysiological effects of repetitive transcranial magnetic stimulation (rTMS) in treatment resistant depression
Daphne Voineskos et al.
CLINICAL NEUROPHYSIOLOGY (2021)
Nucleotide distance influences co-methylation between nearby CpG sites
Ornella Affinito et al.
GENOMICS (2020)
Impact of sleep on complicated grief severity and outcomes
Kristin L. Szuhany et al.
DEPRESSION AND ANXIETY (2020)
Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report
Antoine Yrondi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete et al.
FRONTIERS IN PSYCHIATRY (2020)
A comparison of penalised regression methods for informing the selection of predictive markers
Christopher J. Greenwood et al.
PLOS ONE (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling
Shan-shan Xue et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
Chelsey Ju et al.
TRANSLATIONAL PSYCHIATRY (2019)
Genome-wide association studies of placebo and duloxetine response in major depressive disorder
M. Maciukiewicz et al.
PHARMACOGENOMICS JOURNAL (2018)
The endocannabinoid system in mental disorders: Evidence from human brain studies
Ines Ibarra-Lecue et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study
Laura Kranaster et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Depression Is the Leading Cause of Disability Around the World
M.J. Friedrich
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease
Danuta M. Jeziorska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors
David V. Sheehan et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2016)
Neurobiological Interactions Between Stress and the Endocannabinoid System
Maria Morena et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
Imke Jenniches et al.
BIOLOGICAL PSYCHIATRY (2016)
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
Raymond W. Lam et al.
BMC PSYCHIATRY (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects
E. Karyotaki et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
Christoph Bock et al.
NATURE BIOTECHNOLOGY (2016)
Hypomethylation of FAM63B in bipolar disorder patients
Anna Starnawska et al.
CLINICAL EPIGENETICS (2016)
Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behavior
Roberta Imperatore et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Dynamic Prediction of Treatment Response in Late-Life Depression
Ian Joel et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
Irena Smaga et al.
NEUROTOXICITY RESEARCH (2014)
IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data
Dan Wang et al.
BIOINFORMATICS (2012)
The Quick Inventory of Depressive Symptomatology, Clinician Rated and Self-report A Psychometric Assessment in Chinese Americans With Major Depressive Disorder
Albert Yeung et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2012)
methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles
Altuna Akalin et al.
GENOME BIOLOGY (2012)
The psychiatric side-effects of rimonabant
Fabricio A. Moreira et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2009)
Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-n-acyl ethanolamine precursors in mouse brain
Gabriel M. Simon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents
Matthew N. Hill et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Serum endocannabinoid content is altered in females with depressive disorders: A preliminary report
M. N. Hill et al.
PHARMACOPSYCHIATRY (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A brief measure for assessing generalized anxiety disorder -: The GAD-7
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia
FA Middleton et al.
JOURNAL OF NEUROSCIENCE (2002)
Involvement of CB1 cannabinoid receptors in emotional behaviour
M Martin et al.
PSYCHOPHARMACOLOGY (2002)
分享论文
